Amyloid pathology occurs early in Alzheimer's disease (AD), and has therefore been the focus of numerous studies. Transgenic mouse models have been instrumental to study amyloidosis, but observations might have been confounded by APP-overexpression artifacts. The current study investigated early functional defects in an APP knock-in mouse model, which allows assessing the effects of pathological amyloid-beta (Aβ) without interference of APP-artifacts. Female APP knock-in mice of 3 and 7 months old were compared to age-matched APP mice with increased Aβ42/40 ratio and initial Aβ-plaque deposition around 6 months of age. Spatial learning was examined using a Morris water maze protocol consisting of acquisition and reversal trials interleaved ...
The synaptic changes underlying the onset of cognitive impairment in Alzheimer’s disease (AD) are po...
Abstract Background Knock-in (KI) mouse models of Alzheimer’s disease (AD) that endogenously overpro...
Alzheimer’s disease is a neurodegenerative disease that has many pathological features including; pl...
Amyloid pathology occurs early in Alzheimer's disease (AD), and has therefore been the focus of nume...
Abstract Amyloid pathology occurs early in Alzheimer's disease (AD), and has therefore been the foc...
Multiple animal models have been created to gain insight into Alzheimer's disease (AD) pathology. Am...
Amyloid-β (Aβ) peptides occur in the brains of patients with Alzheimer's disease (AD), but their rol...
Multiple animal models have been created to gain insight into Alzheimer's disease (AD) pathology. Am...
To understand the relationship between amyloid-! and cognitive decline in Alzheimer’s disease, we ev...
Alzheimer's disease is a fatal neurodegenerative disorder affecting the aging population. Neuroimagi...
Mutations in the amyloid precursor protein (APP) gene inducing abnormal processing and deposition of...
Impairment of brain functional connectivity (FC) is thought to be an early event occurring in diseas...
The synaptic changes underlying the onset of cognitive impairment in Alzheimer’s disease (AD) are po...
Preclinical-clinical translation of cognitive functions has been difficult in Alzheimer's disease (A...
The synaptic changes underlying the onset of cognitive impairment in Alzheimer’s disease (AD) are po...
The synaptic changes underlying the onset of cognitive impairment in Alzheimer’s disease (AD) are po...
Abstract Background Knock-in (KI) mouse models of Alzheimer’s disease (AD) that endogenously overpro...
Alzheimer’s disease is a neurodegenerative disease that has many pathological features including; pl...
Amyloid pathology occurs early in Alzheimer's disease (AD), and has therefore been the focus of nume...
Abstract Amyloid pathology occurs early in Alzheimer's disease (AD), and has therefore been the foc...
Multiple animal models have been created to gain insight into Alzheimer's disease (AD) pathology. Am...
Amyloid-β (Aβ) peptides occur in the brains of patients with Alzheimer's disease (AD), but their rol...
Multiple animal models have been created to gain insight into Alzheimer's disease (AD) pathology. Am...
To understand the relationship between amyloid-! and cognitive decline in Alzheimer’s disease, we ev...
Alzheimer's disease is a fatal neurodegenerative disorder affecting the aging population. Neuroimagi...
Mutations in the amyloid precursor protein (APP) gene inducing abnormal processing and deposition of...
Impairment of brain functional connectivity (FC) is thought to be an early event occurring in diseas...
The synaptic changes underlying the onset of cognitive impairment in Alzheimer’s disease (AD) are po...
Preclinical-clinical translation of cognitive functions has been difficult in Alzheimer's disease (A...
The synaptic changes underlying the onset of cognitive impairment in Alzheimer’s disease (AD) are po...
The synaptic changes underlying the onset of cognitive impairment in Alzheimer’s disease (AD) are po...
Abstract Background Knock-in (KI) mouse models of Alzheimer’s disease (AD) that endogenously overpro...
Alzheimer’s disease is a neurodegenerative disease that has many pathological features including; pl...